| Literature DB >> 22474427 |
Maorong Wang1, Mia Crager, Subbiah Pugazhenthi.
Abstract
Human islets isolated for transplantation are exposed to multiple stresses including oxidative stress and hypoxia resulting in significant loss of functional β cell mass. In this study we examined the modulation of apoptosis pathway genes in islets exposed to hydrogen peroxide, peroxynitrite, hypoxia, and cytokines. We observed parallel induction of pro- and antiapoptotic pathways and identified several novel genes including BFAR, CARD8, BNIP3, and CIDE-A. As BNIP3 is an inducer of autophagy, we examined this pathway in MIN6 cells, a mouse beta cell line and in human islets. Culture of MIN6 cells under low serum conditions increased the levels of several proteins in autophagy pathway, including ATG4, Beclin 1, LAMP-2, and UVRAG. Amino acid deprivation led to induction of autophagy in human islets. Preconditioning of islets with inducers of autophagy protected them from hypoxia-induced apoptosis. However, induction of autophagy during hypoxia exacerbated apoptotic cell death. ER stress led to induction of autophagy and apoptosis in β cells. Overexpression of MnSOD, an enzyme that scavenges free radicals, resulted in protection of MIN6 cells from cytokine-induced apoptosis. Ceramide, a mediator of cytokine-induced injury, reduced the active phosphorylated form of Akt and downregulated the promoter activity of the antiapoptotic gene bcl-2. Furthermore, cytokine-stimulated JNK pathway downregulated the bcl-2 promoter activity which was reversed by preincubation with SP600125, a JNK inhibitor. Our findings suggest that β cell apoptosis by multiple stresses in islets isolated for transplantation is the result of orchestrated gene expression in apoptosis pathway.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22474427 PMCID: PMC3310197 DOI: 10.1155/2012/647914
Source DB: PubMed Journal: Exp Diabetes Res ISSN: 1687-5214
Functional grouping of apoptosis pathway genes.
| Bcl-2 family | BAD, BAG1, BAG3, BAG4, BAK1, BAX, BCL2, BCL2A1, BCL2L1, BCL2L10, BCL2L11, BCL2L2, BCLAF1, BID, BIK, BNIP1, BNIP2, BNIP3, BNIP3L, HRK, MCL1 |
| Caspase family | CASP1, CASP10, CASP14, CASP2, CASP3, CASP4, CASP5, CASP6, CASP7, CASP8, CASP9 |
| IAP family | BIRC1, BIRC2, BIRC3, BIRC4, BIRC6, BIRC8 |
| TRAF family | TRAF2, TRAF3, TRAF4 |
| CARD family | APAF1, BCL10, BIRC2, BIRC3, CARD4, CARD6, CARD8, CASP1, CASP2, CASP4, CASP5, CASP9, CRADD, NOL3, PYCARD, RIPK2 |
| Death domain family | CRADD, DAPK1, FADD, FAS (TNFRSF6), TNFRSF10A, TNFRSF10B, TNFRSF11B, TNFRSF1A, TNFRSF21, TNFRSF25, TRADD |
| Death effector domain family | CASP8, CASP10, CFLAR, FADD |
| CIDE domain family | CIDE-A, CIDE-B, DFFA |
| p53 and DNA damage response | ABL1, AKT1, APAF1, BAD, BAX, BCL2, BCL2L1, BID, CASP3, CASP6, CASP7, CASP9, GADD45A, TP53, TP53BP2, TP73 |
| Anti-apoptosis | AKT1, BAG1, BAG3, BCL2, BCL2A1, BCL2L1, BCL2L10, BCL2L2, BFAR, BIRC1, BIRC2, BIRC3, BIRC4, BIRC6, BIRC8, BNIP1, BNIP2, BNIP3, BRAF, CFLAR, IGF1R, MCL1, TNFRSF7 |
| TNF ligand family | CD40LG (TNFSF5), FASLG (TNFSF6), LTA, TNF, TNFSF10, TNFSF7, TNFSF8 |
| TNF receptor family | CD40 (TNFRSF5), FAS (TNFRSF6), LTBR, TNFRSF10A, TNFRSF10B, TNFRSF11B, TNFRSF1A, TNFRSF1B, TNFRSF21, TNFRSF25, TNFRSF7, TNFRSF9 |
Mean fold (>2.0) changes in apoptosis pathway gene expression in islets after exposure to oxidative stress (H2O2 and peroxynitrite), hypoxia, and cytokines.
| Genes | Role in apoptosis | Peroxynitrite | H2O2 | Hypoxia | Cytokines |
|---|---|---|---|---|---|
| Bcl2A1 | Anti-apoptotic; Bcl2 family | 3.2 | 2.1 | 2.4 | 11.4 |
| Bid | Proapoptotic; BH3 only | 3.7 | 3.5 | 2.5 | 3.4 |
| Fas | Extrinsic; receptor | 4.3 | 3.1 | 3.4 | 7.4 |
| Fas ligand | Extrinsic; receptor ligand | 2.4 | 2.1 | NS | 3.4 |
| TRAIL | Extrinsic; receptor ligand | 4.6 | 3.6 | NS | 4.2 |
| A20 | Extrinsic; anti-apoptotic | 2.3 | NS | 2.5 | 7.4 |
| c-Flip | Extrinsic; anti-apoptotic | 2.6 | NS | NS | 4.2 |
| Caspase-3 | Marker for apoptosis | 4.5 | 3.2 | 3.2 | 2.3 |
| BIRC3 | Caspase inhibitor | 3.2 | 2.4 | NS | 8.7 |
| CARD8 | Caspase-9 inhibitor | −2.3 | −2.4 | −2.1 | −2.3 |
| BRAF | Signaling kinase | −3.7 | −3.5 | −2.5 | NS |
| BFAR | Anti-apoptotic; links both pathways | −4.8 | −3.5 | −4.2 | NS |
| CIDE-A | Causes DNA fragmentation | 3.2 | 2.4 | 3.8 | NS |
| BNIP3 | Autophagy Inducer | 2.6 | NS | 5.6 | NS |
Human islets (2000 IEQ) were exposed to 200 μM of peroxynitrite, 200 μM of H2O2 or a mixture of cytokines (2 ng/mL of IL-1β, 10 ng/mL of TNF-α and 10 ng/mL of IFN-γ) for 24 h or cultured under hypoxic conditions (1% oxygen) for 8 h. The cDNA synthesized from isolated RNA was mixed with Master Mix containing SYBR Green and distributed into 96 wells containing primers for the 84 genes associated with the apoptotic pathway. Five housekeeping control genes and three RNA and PCR quality controls were also included. PCR analysis was carried out and the fold changes between control and treated were calculated based on ΔC and corrected for GAPDH expression. Results are the mean obtained from four different batches of human islets. NS: not significant.
Figure 1Stress-induced modulation of genes in apoptosis pathway. Human islets (2000 IEQ) cultured in Miami medium were exposed to multiple stresses including peroxynitrite (PN; 200 μM), H2O2 (200 μM), or a mixture of cytokines (Cyt; 2 ng/mL of IL-1β, 10 ng/mL of TNF-α, and 10 ng/mL of IFN-γ) for 24 h or cultured under hypoxic conditions (1% oxygen) for 8 h. RNA was isolated from treated islets for the RT-PCR analysis of BFAR, CARD8, CIDE-A, and BNIP3 using Taqman probes. Results are M ± SE of experiments with four independent batches of human islets. *P < 0.01; **P < 0.001 when compared to untreated control (Con).
Figure 2Induction of autophagy in MIN6 cells. (a) MIN6 cells grown to 60% confluence were incubated in low (0.1%) serum or regular (10%) serum medium in the presence of increasing concentrations of trehalose, an inducer of autophagy, for 24 h. (b) MIN6 cells were preincubated in the presence of 10 mM of 3-methyladenine (3MA) or 100 nM of bafilomycin A1 (Bf) for 20 min followed by exposure to 100 mM of trehalose for 24 h. (c) ER stress was induced in MIN6 cells by culturing them in the presence of thapsigargin (Th; 100 nM) or tunicamycin (Tu; 1 μg/mL) for 24 h. Lysates of the treated cells ((a)–(c)) were analyzed by Western blotting for markers of autophagy. Representative images from three independent experiments are presented.
Figure 3Induction of autophagy in human islets. (a) Human islets were incubated for 8 h in Miami medium (control) or in Hank's balanced salt solution for amino acid (AA) starvation. Treated islets were fixed in paraformaldehyde and embedded in OCT. Frozen sections (7 μm thickness) were immunostained for insulin with FITC (Green) and for LC3-II with cy3 (red). Formation of autophagosomes was visualized by the punctated staining of LC3-II in β cells (arrows). (b) Human islets were cultured under normoxic or hypoxic conditions in the absence and presence of inducers of autophagy, trehalose, rapamycin (Rapa) or salt solution (Salt) for 8 h. Cell lysates were processed for Western blot analysis of the active form of caspase-3. Induction of autophagy during hypoxia exacerbated apoptosis in islets. (c) Human islets were preincubated with inducers of autophagy for 4 h. Following change of medium, the cells were cultured under normoxic or hypoxic conditions for 12 h, lysed and processed for the Western blot analysis of active caspase-3. Autophagic preconditioning protected islets from hypoxia-induced apoptosis. Representative images from experiments with three independent batches of human islets are presented.
Figure 4Antiapoptotic actions of MnSOD and exendin-4 in MIN6 cells: MIN6 cells cultured on chamber slides were transfected with cDNA encoding MnSOD-GFP chimeric protein. The transfected cells were exposed to a mixture of cytokines (2 ng of IL-1β, 10 ng of TNF-α and 10 ng of IFN-γ) for 24 h. The cells were fixed, permeabilized and probed with antibodies specific for the active cleaved fragment of caspase-9 (a) and caspase-3 (b). This was followed by probing with secondary antibodies linked to Cy3. The images were analyzed by digital deconvolution microscopy. The cells expressing MnSOD (green) are protected from cytokine-induced apoptosis. Images from three independent experiments are presented. (c) MIN6 cells were cultured in the absence and presence of exendin-4 (50 nM). ER stress was induced by exposing the cells to thapsigargin (Th; 100 nM) or tunicamycin (Tu; 1 μg/mL) for 24 h. Lysates of the treated cells were analyzed by Western blotting for active caspase-3 and β actin. Band intensities were quantitated by scanning. Results are M ± SE of three independent experiments. **P < 0.001 when compared to untreated control. *P < 0.01 versus respective ER stress control in the absence of exendin-4.
Figure 5Ceramide is a mediator of cytokine-mediated CREB downregulation. (a) Human islets were exposed to C2 (10 μM), a synthetic ceramide, for 24 h. The islets were fixed and immunostained for phospho Akt (Thr 308). The images were analyzed by digital deconvolution microscopy. Decrease in the active form of Akt was observed in ceramide-treated islets. (b) Islets were incubated in the absence and presence of C2 and a combination of cytokines for 24 h and processed for the Western blot analysis of phosphorylated form of CREB, total CREB and β actin. Band intensities were quantitated by scanning. The results are M ± SE of 3 independent experiments. *P < 0.01; **P < 0.001; # P < 0.05 compared to untreated control. Active form of CREB was decreased by both C2 and cytokines. (c) MIN6 cells were transfected with a CRE site-containing bcl-2 promoter linked to a firefly luciferase reporter and a constitutively active renilla luciferase (for transfection efficiency). The transfected cells were exposed to increasing concentrations of C2 and 50 μM of an inactive analogue (dh) for 24 h. The cells were processed for luciferase activities using a dual luciferase assay kit. The ratio of firefly and renilla luciferase activities was taken as a measure of bcl-2 promoter activity. Bcl-2 promoter activity was inhibited by the ceramide. The results are M ± SE of 4 independent experiments. *P < 0.01; **P < 0.001 compared to untreated control.
Figure 6Activation of JNK by cytokines. (a) MIN6 cells were incubated in the absence and presence of 20 μM JNK inhibitor, SP600125 and/or a combination of cytokines, IL-1β (2 ng/mL) TNF-α (10 ng/mL) and IFN-γ (10 ng/mL) for the indicated time periods. The treated cells were processed for the Western blot analysis of phosphorylated (Phos) c-jun, total c-jun, phosphorylated (Phos) JNK and total JNK. ((b) and (c)) MIN6 cells were transfected with a CRE site-containing bcl-2 promoter linked to a firefly luciferase reporter and a constitutively active renilla luciferase. A combination of plasmid mixture encoding the JNK isozymes or their vector was also included for one experiment (b). Transfected cells were incubated in the absence and presence of a combination of cytokines and JNK inhibitor (SP600125) as indicated for 24 h followed by the assay for luciferases. Bcl-2 promoter activity was inhibited by cytokines and JNK isozymes. Cytokine action on bcl-2 promoter activity was blocked by the JNK inhibitor. The results are M ± SE of 4 independent experiments. *P < 0.01; **P < 0.001 versus untreated control.
Figure 7Interactions of signaling by ER stress, oxidative stress, and cytokines with the pathways of autophagy: Induction of autophagy requires the assembly of Beclin-1 with class III PI 3 kinase (Vps34) and UVRAG. Rapamycin is an activator of autophagy as it is negatively regulated by class I PI 3 kinase through mammalin target of rapamycin (mTOR). The elongation step involves two ubiquitin-like conjugation system. ATG12 is activated by E1-like ATG7, transferred to E2-like ATG10 and conjugated to ATG5. Similarly, LC3-I is activated by E1-like ATG7, transferred to E2-like ATG3, and conjugated to phosphatidylethanolamine (PE). Inhibitors of autophagy include 3 methyl adenine which inhibits class III PI 3-K and bafilomycin A1 which inhibits the formation of autophagolysosome. Interaction of Bcl-2 with Beclin-1 keeps the autophagic pathway under control. CREB induces the expression of Bcl-2 which is downregulated by ER stress, oxidative stress and cytokines through JNK.